COSTECH Integrated Repository

Inhibited carnitine synthesis causes systemic alteration of nutrient metabolism in zebrafish.

Show simple item record

dc.creator Jia-Min, Li
dc.creator Ling-Yu, Li
dc.creator Xuan, Qin
dc.creator Pascal, Degrace
dc.creator Laurent Demizieux, Demizieux
dc.creator Samwel Mchele Limbu
dc.creator Xin, Wang
dc.creator Mei-Ling, Zhang
dc.creator Dong-Liang, Li
dc.creator Zhen-Yu Du, Du
dc.date 2019-05-07T13:06:05Z
dc.date 2019-05-07T13:06:05Z
dc.date 2018-05-09
dc.date.accessioned 2021-05-07T07:47:50Z
dc.date.available 2021-05-07T07:47:50Z
dc.identifier Frontiers in Physiology
dc.identifier http://hdl.handle.net/20.500.11810/5223
dc.identifier https://doi.org/10.3389/fphys.2018.00509
dc.identifier.uri http://hdl.handle.net/20.500.11810/5223
dc.description Impaired mitochondrial fatty acid β-oxidation has been correlated with many metabolic syndromes, and the metabolic characteristics of the mammalian models of mitochondrial dysfunction have also been intensively studied. However, the effects of the impaired mitochondrial fatty acid β-oxidation on systemic metabolism in teleost have never been investigated. In the present study, we established a low-carnitine zebrafish model by feeding fish with mildronate as a specific carnitine synthesis inhibitor [0.05% body weight (BW)/d] for 7 weeks, and the systemically changed nutrient metabolism, including carnitine and triglyceride (TG) concentrations, fatty acid (FA) β-oxidation capability, and other molecular and biochemical assays of lipid, glucose, and protein metabolism, were measured. The results indicated that mildronate markedly decreased hepatic carnitine concentrations while it had no effect in muscle. Liver TG concentrations increased by more than 50% in mildronate-treated fish. Mildronate decreased the efficiency of liver mitochondrial β-oxidation, increased the hepatic mRNA expression of genes related to FA β-oxidation and lipolysis, and decreased the expression of lipogenesis genes. Mildronate decreased whole body glycogen content, increased glucose metabolism rate, and upregulated the expression of glucose uptake and glycolysis genes. Mildronate also increased whole body protein content and hepatic mRNA expression of mechanistic target of rapamycin (mtor), and decreased the expression of a protein catabolism-related gene. Liver, rather than muscle, was the primary organ targeted by mildronate. In short, mildronate-induced hepatic inhibited carnitine synthesis in zebrafish caused decreased mitochondrial FA β-oxidation efficiency, greater lipid accumulation, and altered glucose and protein metabolism. This reveals the key roles of mitochondrial fatty acid β-oxidation in nutrient metabolism in fish, and this low-carnitine zebrafish model could also be used as a novel fish model for future metabolism studies.
dc.description National Basic Research Program of China (973 Program 2014CB138603) and National Natural Science Fund (31772859 and 31472290).
dc.subject low carnitine zebrafish
dc.subject mildronate
dc.subject FA β-oxidation
dc.subject dyslipidemia
dc.subject metabolism
dc.title Inhibited carnitine synthesis causes systemic alteration of nutrient metabolism in zebrafish.
dc.type Journal Article, Peer Reviewed


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search COSTECH


Advanced Search

Browse

My Account